Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis — Stella

View on ClinicalTrials.gov

Recruiting

Back to Sepsis trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Egypt

Assiut university hospital, Asyut

Key details

Phase

Large-scale testing

Sponsor

Assiut University

Enrollment target

~80 participants

Started

June 2021

Primary completion

January 2027

Age range

18 Years – 65 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.